Search

everythinglearnresearchcommunity

for

Search:↓

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

These chemicals can be toxic and cause health issues like irritation, liver damage, and cancer.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Scalp cooling can effectively reduce hair loss during chemotherapy, with modern methods improving comfort and accessibility.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

Stopping azathioprine improved hair loss and bone marrow issues.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Image analysis can effectively identify changes in scalps affected by chemotherapy-induced hair loss.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Analog 23 is a promising compound for prostate cancer treatment.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Scalp cryotherapy significantly reduces hair loss during and shortly after chemotherapy.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.